These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2438715)

  • 21. [The prognosis of Graves' disease after antithyroid drug treatment: clinical significance of the T3 suppression test and abnormal thyroid stimulators].
    Iida Y; Konishi J; Kasagi K; Misaki T; Endo K; Nesumi N; Torizuka K; Tanaka K; Ishii H; Naito K; Nishikawa M; Inada M; Imura H; Kuma K
    Nihon Naibunpi Gakkai Zasshi; 1982 Jun; 58(6):796-806. PubMed ID: 6180937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization and clinical assessment of a radioreceptor assay for thyrotropin-binding inhibitor immunoglobulins.
    Konishi J; Kasagi K; Iida Y; Kousaka T; Misaki T; Arai K; Tokuda Y; Torizuka K
    Endocrinol Jpn; 1987 Feb; 34(1):13-20. PubMed ID: 2440665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope heterogeneity of thyroid-stimulating antibodies predicts long-term outcome in Graves' patients treated with antithyroid drugs.
    Kim TY; Park YJ; Park DJ; Chung HK; Kim WB; Kohn LD; Cho BY
    J Clin Endocrinol Metab; 2003 Jan; 88(1):117-24. PubMed ID: 12519839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of a correlation between thyrotrophin receptor binding inhibition and thyroid adenylate cyclase activation by immunoglobulins in Graves' disease before and during long-term antithyroid treatment.
    Bliddal H; Bech K; Hyltoft Petersen P; Siersbaek-Nielsen K; Friis T
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):35-40. PubMed ID: 6181640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?
    Schleusener H; Finke R; Kotulla P; Wenzel KW; Meinhold H; Roedler HD
    J Endocrinol Invest; 1978 Apr; 1(2):155-61. PubMed ID: 90689
    [No Abstract]   [Full Text] [Related]  

  • 26. A patient with Graves' disease who developed hypothyroidism associated with thyroid stimulation blocking immunoglobulin during anti-thyroid drug therapy.
    Inomata H; Tsuyusaki T; Sasaki N; Tamaru K; Niimi H; Nakajima H
    Endocrinol Jpn; 1988 Jun; 35(3):379-84. PubMed ID: 2461854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ANCA in Graves' disease--is it antithyroid medication-induced?
    Prakash EB
    J Assoc Physicians India; 2009 Jul; 57():545; author reply 545. PubMed ID: 20329422
    [No Abstract]   [Full Text] [Related]  

  • 28. TSH-receptor antibodies in mothers with Graves' disease and outcome in their offspring.
    Matsuura N; Konishi J; Fujieda K; Kasagi K; Iida Y; Hagisawa M; Fujimoto S; Fukushi M; Takasugi N
    Lancet; 1988 Jan 2-9; 1(8575-6):14-7. PubMed ID: 2891888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The challenge of treating Graves'-Basedow's disease patients with antithyroid drugs (ATD) in a large university hospital.
    Iacona A; Lima N; Perozim LM; Knobel M; Cavaliere H; Medeiros-Neto G
    Exp Clin Endocrinol; 1991 May; 97(2-3):297-302. PubMed ID: 1717299
    [No Abstract]   [Full Text] [Related]  

  • 30. The long-term follow-up of patients with thionamide-treated Graves' hyperthyroidism.
    Bandai S; Okamura K; Fujikawa M; Sato K; Ikenoue H; Kitazono T
    Endocr J; 2019 Jun; 66(6):535-545. PubMed ID: 30918165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological parameters in Graves' disease: are they useful for indication and monitoring of antithyroid drug treatment?
    Orgiazzi J; Madec AM; Genetet N; Gueguen M; Allannic H
    Horm Res; 1987; 26(1-4):131-6. PubMed ID: 2439426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating immune complexes and thyroid-stimulating immunoglobulins before, during, and after antithyroid drug therapy in patients with Graves' disease.
    van der Heide D; Daha MR; Bolk JH; Bussemaker JK; de Bruin TW; Goslings BM; van Es LA; Querido A
    Lancet; 1980 Jun; 1(8183):1376-9. PubMed ID: 6155582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative measurement of anti-TSH receptor antibodies is useful for the evaluation of treatment effect.
    Amino N; Kubota S; Morita S; Fukata S; Miyauchi A
    Thyroid; 2007 Jan; 17(1):85-6. PubMed ID: 17274759
    [No Abstract]   [Full Text] [Related]  

  • 34. [Guideline for the treatment of Graves' disease with antithyroid drug].
    Nakamura H
    Nihon Rinsho; 2006 Dec; 64(12):2189-93. PubMed ID: 17154077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Theoretical aspects of the treatment with antithyroid drugs].
    Orgiazzi J; Millot L
    Ann Endocrinol (Paris); 1994; 55(1):1-5. PubMed ID: 7528484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical aspects on surgery in Graves' disease. Clinical review.
    Karlsson FA; Winsa B; Rastad J; Johansson H
    Acta Chir Scand; 1990 Jan; 156(1):47-51. PubMed ID: 1690941
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence that antithyroid drugs induce remissions in Graves' disease by modulating thyroid cellular activity.
    Volpé R; Karlsson A; Jansson R; Dahlberg PA
    Clin Endocrinol (Oxf); 1986 Oct; 25(4):453-62. PubMed ID: 2441908
    [No Abstract]   [Full Text] [Related]  

  • 38. How antithyroid drugs work in Graves' disease.
    Weetman AP
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):317-8. PubMed ID: 1282852
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of thyroid-stimulating antibodies in sera of patients with Graves' disease--clinical and experimental studies.
    Chen G; Ye WX
    J Tongji Med Univ; 1987; 7(1):35-9. PubMed ID: 2885423
    [No Abstract]   [Full Text] [Related]  

  • 40. Carbimazole treatment in smokers vs nonsmokers with Graves disease.
    Shin JI; Lee JS
    JAMA; 2009 May; 301(19):1988-9; author reply 1989. PubMed ID: 19454634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.